Disclosures for "Discontinuation of Infliximab in Neurosarcoidosis"
-
Dr. Maher has nothing to disclose.
-
Ms. Lengel has nothing to disclose.
-
Jeffrey Shen has nothing to disclose.
-
Dr. Mendez Colmenares has nothing to disclose.
-
Dr. Lackey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Lackey has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Lackey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Doximity.